With significant technology advances in ECG recording through the years, the need to expand on traditional monitoring baselines—and include new variables such as time when designing clinical trial protocols—is important.
This article explores the many challenges to creating a pharmaceutical development program for the treatment of a rare disease.
By Applied Clinical Trials Editors
The EU-AIMS Longitudinal European Autism Project (LEAP) is combining genetic testing, neuroimaging, cognitive testing and clinical assessments to identify biological risk markers associated with subtypes of autism.
Alzheimer’s disease is and will remain one of the most unyielding public health crises of the 21st century.
ERT announces it has successfully integrated the fractional exhaled Nitric Oxide (FeNO) measurement device by Aerocrine, a Circassia subsidiary, into it’s diagnostic platform for spirometry, ECG and home monitoring for centralized clinical trials.